Cumberland Pharmaceuticals Stock Performance

CPIX Stock  USD 3.92  0.00  0.00%   
Cumberland Pharmaceuticals holds a performance score of 14 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.73, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cumberland Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cumberland Pharmaceuticals is expected to be smaller as well. Use Cumberland Pharmaceuticals treynor ratio, as well as the relationship between the expected short fall and day typical price , to analyze future returns on Cumberland Pharmaceuticals.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain forward indicators, Cumberland Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(1.81)
Five Day Return
5.87
Year To Date Return
(4.77)
Ten Year Return
(24.35)
All Time Return
(77.48)
Last Split Factor
2:1
Last Split Date
2007-07-06
1
Acquisition by Krogulski Kenneth of 117 shares of Cumberland Pharmaceuticals at 2.17 subject to Rule 16b-3
11/17/2025
2
Acquisition by Krogulski Kenneth of 117 shares of Cumberland Pharmaceuticals at 1.98 subject to Rule 16b-3
11/18/2025
3
Acquisition by Krogulski Kenneth of 117 shares of Cumberland Pharmaceuticals at 1.96 subject to Rule 16b-3
11/21/2025
4
Acquisition by Krogulski Kenneth of 124 shares of Cumberland Pharmaceuticals at 2.21 subject to Rule 16b-3
11/25/2025
5
Acquisition by Krogulski Kenneth of 124 shares of Cumberland Pharmaceuticals at 2.41 subject to Rule 16b-3
11/28/2025
6
CALDOLOR INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT
12/08/2025
7
RedHill Biopharmas Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
12/15/2025
8
Acquisition by Krogulski Kenneth of tradable shares of Cumberland Pharmaceuticals at 4.19 subject to Rule 16b-3
12/18/2025
9
Acquisition by Krogulski Kenneth of tradable shares of Cumberland Pharmaceuticals at 4.32 subject to Rule 16b-3
12/22/2025
10
Acquisition by Krogulski Kenneth of tradable shares of Cumberland Pharmaceuticals at 4.26 subject to Rule 16b-3
12/24/2025
11
Acquisition by Krogulski Kenneth of tradable shares of Cumberland Pharmaceuticals at 4.21 subject to Rule 16b-3
12/26/2025
12
Acquisition by Krogulski Kenneth of tradable shares of Cumberland Pharmaceuticals at 4.01 subject to Rule 16b-3
12/29/2025
13
Acquisition by Krogulski Kenneth of tradable shares of Cumberland Pharmaceuticals at 3.91 subject to Rule 16b-3
12/31/2025
14
Acquisition by Young Caroline of tradable shares of Cumberland Pharmaceuticals at 4.21 subject to Rule 16b-3
01/06/2026
15
Is Cumberland Pharmaceuticals Inc. stock a safe buy before earnings - 2025 Technical Overview Target Return Focused Picks - ulpravda.ru
01/08/2026
16
Niche Focus Regulation Shape the Future of Healthcare Firms
01/15/2026
17
Acquisition by Young Caroline of tradable shares of Cumberland Pharmaceuticals at 3.91 subject to Rule 16b-3
01/16/2026
18
Gap Down Why is Cumberland Pharmaceuticals Inc stock going up - 2025 Growth vs Value Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
01/26/2026
Begin Period Cash Flow18.3 M
Total Cashflows From Investing Activities57.8 K

Cumberland Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  219.00  in Cumberland Pharmaceuticals on November 6, 2025 and sell it today you would earn a total of  167.00  from holding Cumberland Pharmaceuticals or generate 76.26% return on investment over 90 days. Cumberland Pharmaceuticals is currently generating 1.1214% in daily expected returns and assumes 6.0649% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Cumberland, and 78% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 8.07 times more return on investment than the market. However, the company is 8.07 times more volatile than its market benchmark. It trades about 0.18 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Cumberland Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Cumberland Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.92 90 days 3.92 
about 26.79
Based on a normal probability distribution, the odds of Cumberland Pharmaceuticals to move above the current price in 90 days from now is about 26.79 (This Cumberland Pharmaceuticals probability density function shows the probability of Cumberland Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Cumberland Pharmaceuticals has a beta of 0.73 suggesting as returns on the market go up, Cumberland Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cumberland Pharmaceuticals will be expected to be much smaller as well. Additionally Cumberland Pharmaceuticals has an alpha of 0.3824, implying that it can generate a 0.38 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Cumberland Pharmaceuticals Price Density   
       Price  

Predictive Modules for Cumberland Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cumberland Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.193.789.84
Details
Intrinsic
Valuation
LowRealHigh
0.244.8010.86
Details
Naive
Forecast
LowNextHigh
0.083.789.85
Details
1 Analysts
Consensus
LowTargetHigh
7.748.509.44
Details

Cumberland Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cumberland Pharmaceuticals is not an exception. The market had few large corrections towards the Cumberland Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cumberland Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cumberland Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.38
β
Beta against Dow Jones0.73
σ
Overall volatility
1.05
Ir
Information ratio 0.06

Cumberland Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cumberland Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cumberland Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cumberland Pharmaceuticals is way too risky over 90 days horizon
Cumberland Pharmaceuticals appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 37.87 M. Net Loss for the year was (6.48 M) with profit before overhead, payroll, taxes, and interest of 34.88 M.
Cumberland Pharmaceuticals currently holds about 18.22 M in cash with (612.19 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Cumberland Pharmaceuticals has a poor financial position based on the latest SEC disclosures
Roughly 42.0% of the company shares are held by company insiders
Latest headline from news.google.com: Gap Down Why is Cumberland Pharmaceuticals Inc stock going up - 2025 Growth vs Value Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Cumberland Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cumberland Stock often depends not only on the future outlook of the current and potential Cumberland Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cumberland Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.1 M
Cash And Short Term Investments18 M

Cumberland Pharmaceuticals Fundamentals Growth

Cumberland Stock prices reflect investors' perceptions of the future prospects and financial health of Cumberland Pharmaceuticals, and Cumberland Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cumberland Stock performance.

About Cumberland Pharmaceuticals Performance

Evaluating Cumberland Pharmaceuticals' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Cumberland Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cumberland Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 199.51  325.49 
Return On Tangible Assets(0.13)(0.12)
Return On Capital Employed(0.17)(0.16)
Return On Assets(0.10)(0.09)
Return On Equity(0.33)(0.31)

Things to note about Cumberland Pharmaceuticals performance evaluation

Checking the ongoing alerts about Cumberland Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cumberland Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cumberland Pharmaceuticals is way too risky over 90 days horizon
Cumberland Pharmaceuticals appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 37.87 M. Net Loss for the year was (6.48 M) with profit before overhead, payroll, taxes, and interest of 34.88 M.
Cumberland Pharmaceuticals currently holds about 18.22 M in cash with (612.19 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Cumberland Pharmaceuticals has a poor financial position based on the latest SEC disclosures
Roughly 42.0% of the company shares are held by company insiders
Latest headline from news.google.com: Gap Down Why is Cumberland Pharmaceuticals Inc stock going up - 2025 Growth vs Value Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Evaluating Cumberland Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cumberland Pharmaceuticals' stock performance include:
  • Analyzing Cumberland Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cumberland Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Cumberland Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cumberland Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cumberland Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cumberland Pharmaceuticals' stock. These opinions can provide insight into Cumberland Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cumberland Pharmaceuticals' stock performance is not an exact science, and many factors can impact Cumberland Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.